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Background: Bone marrow-derived macrophages (BMDMs) are widely used primary cells for studying macrophage
function. However, despite numerous protocols that are currently available, lack of a notable consensus on
generating BMDMs may obscure the reliability in comparing findings from different studies or laboratories.
Findings: In this study, we addressed the effect of cell density on the resulting macrophage population. With
reference to previously published methods, bone marrow cells from wild type C57BL/6 mice were plated at either
4 × 105 cells or 5 × 106 cells per 10 cm and cultured in 20% L-cell conditioned media for 7 days, after which they were
analyzed for cell surface markers, production of proinflammatory cytokines, and responsiveness to polarizing signals.
Reproducibly, cells plated at lower density gave a pure population of CD11b+F4/80+ macrophages (97.28 ± 0.52%) with
majority being Ly-6C-Ly-6G- and c-Fms+, while those plated at higher density produced less CD11b+F4/80+ cells and a
considerably higher proportion of CD11b+F4/80+CD11c+ (68.72 ± 2.52%) and Ly-6C-Ly-6G+ (71.10 ± 0.90%) cells. BMDMs
derived from higher plating density also secreted less proinflammatory cytokines such as IL-6, IL-12 and TNF-α and
were less phagocytic, and had a different pattern of expression for M1- and M2-related genes upon LPS or IL-4
stimulation.
Conclusions: Overall, our findings indicate that altering cell density during BMDM differentiation can give rise to
distinct macrophage populations that could vary the outcome of a functional study.
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Bone marrow-derived macrophages (BMDMs) are
commonly used but methods are not conformed
Macrophages are phagocytic cells which play a crucial role
in the first line of defense against pathogens and environ-
mental toxins, and provide a link between innate and
adaptive immune response. They express a wide range of
Toll-like receptors (TLRs) and pattern-recognition recep-
tors (PRRs) to detect endogenous danger signals and dis-
play an incredible plasticity, where their functions can be
significantly and specifically altered by surrounding cyto-
kines [1]. As a model system to study the function of this
highly diversified and complex cell type, bone marrow-
derived macrophages (BMDM) differentiated in vitro from
bone marrow myeloid progenitors have enabled gene* Correspondence: jim.hu@utoronto.ca
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reproduction in any medium, provided the orfunction studies in macrophages in general, as well as pro-
viding an abundant source of primary cells that are other-
wise difficult to obtain. However, despite decades of
application in a wide variety of experimental settings,
there has not been a uniformly agreed BMDM culture
method that is available to the scientific community. This
notable lack of consensus on generating BMDMs may ob-
scure the reliability in comparing findings from different
studies or laboratories, as publications often do not pro-
vide detailed description of the procedures involved in the
generation of primary cells.
Culturing of bone marrow cells under different densities
during in vitro differentiation
To generate BMDMs, the myeloid progenitor cells isolated
from the bone marrow are cultured in the presence of
macrophage colony-stimulating factor (M-CSF), which
signals through its receptor M-CSFR (= c-Fms) to mediate
monocytic lineage proliferation and differentiation [2,3].
M-CSF is now commercially available as a recombinanttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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conditioned media. To test the reliability of utilizing differ-
ent BMDM culture methods, we analyzed the effect of cell
density during BMDM differentiation on the resulting
macrophage population, as different plating density evi-
dently varied between established protocols. With refer-
ence to previously published methods (such as [4-7]),
bone marrow (BM) was flushed from femur and tibia of
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Figure 1 Differentiation of bone marrow cells at different densities re
higher density produces (a) smaller and rounder macrophages, with top p
phase contrast images; (b) less CD11b+F4/80+ cells but more CD11b+F4/80
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primary antibodies, using unstained cells and isotype antibodies as negativ
exclusion. Data was acquired by BD LSRII flow cytometer and analyzed wit
experiments of three independent samples each, and statistical analysis wa
*** P < 0.0005; ** P < 0.005; * P < 0.05.single cell suspension after red blood cell (RBC) lysis and
were plated at either 4 × 105 cells or 5 × 106 cells per
10 cm non-tissue culture-treated petri dishes in 10 mL of
20% L-929-conditioned media (20% L-cell conditioned
media, 10% FBS, 2 mM L-glutaMAX, 10 IU/mL penicillin
and 10 μg/mL streptomycin in 1× RPMI). On Day 3, add-
itional 5 mLs of the growth media were added per petri
dish and cells were harvested for assays on Day 7. The two
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phagocytosis, and expression of macrophage polarization
genes. All animal work was performed in compliance with
The Toronto Centre for Phenogenomics (TCP) Animal
Care Committee (ACC)’s guidelines and approved Animal
Use Protocol (AUP#0062).
Macrophages grown under different cell densities express
distinct cell surface markers
Flow cytometric analysis of monocytic/macrophage
maturation markers of BMDMs generated under low
(4 × 105) or high (5 × 106) plating concentrations re-
vealed that the same bone marrow cells grown under
different densities can give rise to phenotypically dis-
tinct populations (Figure 1). Reproducibly, cells plated
at lower density gave a pure population of CD11b+F4/(a)
(b)
Figure 2 Functional comparison of BMDMs differentiated under diffe
measured from culture supernatant using ELISA kits from Peprotech follow
and stimulated with 100 ng/mL LPS (Escherichia coli serotype 0128:B12, Sig
1x105 cells on a 96-well plate in triplicates and incubating with fluorescein-
signals were blocked with trypan blue. Fluorescence was detected on the
excitation and 520 nm emission wavelengths. (c) Presence of nitric oxide (
measured colometrically using Greiss reagent (Molecular Probes) following
three biological samples each. Statistical analysis was done by one-way AN80+ macrophages (97.28 ± 0.52%) (Figure 1b) with ma-
jority being Ly-6C-Ly-6G- (60.46 ± 2.88%) and c-Fms+
(86.70 ± 2.95%) (Figure 1c, d) which denotes a mature
phenotype [8], while those plated at higher density pro-
duced less CD11b+F4/80+ (89.18 ± 1.14%) cells and a
considerably higher proportion of CD11c+ (68.72 ± 2.52%)
and Ly-6C-Ly-6G+ (71.10 ± 0.90%) cells (Figure 1b,d).
Different macrophage differentiation conditions can lead
to functional disparity
To examine whether the observed phenotypic difference
had a functional consequence, BMDMs grown under dif-
ferent densities were compared for their ability to se-
crete cytokines and phagocytose foreign materials.
Noticeably, BMDMs derived from higher plating density
secreted less proinflammatory cytokines such as TNF-α,(c)
rent plating densities. (a) TNF-α, IL-6, IL-12, KC and MIP-1α were
ing the manufacturer’s instructions. Cells were plated on 6-well plates
ma) for 18 hours. (b) Phagocytosis assay was performed by plating
tagged K-12 bioparticle (Invitrogen) for two hours and nonspecific
Molecular Devices Spectra Max 190 microplate reader at 480 nm
NO) in the culture supernatant of the LPS-stimulated BMDM was
the manufacturer’s instructions. Results represent three experiments of
OVA with Bonferroni post-test. *** P < 0.0005; ** P < 0.005; * P < 0.05.
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LPS, were less phagocytic (Figure 2b), and had a differ-
ent pattern of expression for M1- and M2-related genes
upon LPS or IL-4 stimulation (Figure 3). It was interest-
ing to note, however, that cells grown under higher plat-
ing density displayed increased nitric oxide (NO)
production (Figure 2c), despite the fact that the same
number of live cells (dead cells excluded by trypan blue
staining) of each group were used for functional assays.
In conclusion, our data indicate that BMDM density
during in vitro differentiation can have a functional(a)
(b)
Figure 3 Expression of macrophage polarization genes in BMDMs. (a)
activation with 100 ng/mL LPS for 18 hours and (b) M2 polarization state a
RNA was isolated by GE RNAspin mini kit and reverse transcribed with Sup
SYBERGreen Mastermix. Statistical analysis was done by student t test with
three independent experiments with three biological samples per datapoinimplication on the final macrophage populations, at least
in BMDMs derived from C57BL/6 strain of mice.
Discussion and Concluding Remarks
Cells grown at higher density expressed significantly
higher levels of Ly-6G (=Gr-1) and showed a stronger
tendency towards M2 polarization upon IL-4 treatment
(Figure 3b). Given that CD11b+Ly-6C-Ly-6G- represent a
mature BMDM [8], these cells may be deemed as ‘less
mature’ and points to the possibility that the higher pro-
portion of Ly-6G+ cells resulted from insufficient supplyExpression of genes related to the M1 polarization state upon
fter treatment with 10 ng/mL of IL-4 (Peprotech) for 18 hours. Total
er Script II (Invitrogen) and run on ABI 7500 qPCR machine using ABI
Welch’s correction where appropriate. Result is a representative of
t. *** P < 0.0005; ** P < 0.005; * P < 0.05.
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BM cell ratio required for full BMDM maturation is
currently unknown, and published studies typically use
10-30% L929-conditioned media or 20–100 ng/mL re-
combinant M-CSF over a period of 5–8 days. The possibil-
ity that M-CSF fell short during differentiation of cells
cultured at 5 × 106 density may be tested by growing a
fixed number of BM cells under different known con-
centrations of recombinant M-CSF. Morphologically,
BMDMs matured under higher density tended to be
smaller and rounder (Figure 1a), despite the fact that the
overall final cell density on Day 7 was similar between the
two groups of macrophages. It is thus questionable
whether bone marrow stromal cells that eventually
undergo apoptosis during the in vitro monocytic differen-
tiation might have contributed to this effect. One way to
test the effect of stromal cells in BMDM maturation
would be to co-culture bone marrow stromal cell line such
as M2-10B4 with the myeloid progenitor cells at different
ratios and characterizing the final BMDM population. In
regards to the relationship between the maturation states
of a monocytic cell to their polarization propensity, an
earlier study had indicated that immature macrophages
secrete more IL-12 [9]. However, a maturation status of a
macrophage might be more complex than just defined
by cell surface markers or morphology. Myeloid-derived
suppressor cells (MDSCs), which are known to be
CD11b+Gr-1+ in mice for example, have been demon-
strated to undertake an immunosuppressive role in can-
cer, but monocytic MDSCs produce high levels of NO
[10], which is reflective of characteristics displayed by
the CD11b+Ly-6C-Ly-6G+ BMDMs in this study. There-
fore, this calls for better understanding of monocytic
maturation steps and their corresponding function and
the environmental factors that might influence the
course of maturation, as well as for a commonly
established protocol for BMDM generation to ensure
consistency between studies.
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